'Treatment of COVID-19 with convalescent plasma' - Author's reply.
作者信息
Wooding Denise J, Bach Horacio
机构信息
Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC, Canada.
出版信息
Clin Microbiol Infect. 2021 Apr;27(4):639-640. doi: 10.1016/j.cmi.2020.09.039. Epub 2020 Sep 29.
Abstract
摘要
相似文献
1
'Treatment of COVID-19 with convalescent plasma' - Author's reply.《用康复期血浆治疗新型冠状病毒肺炎》——作者回复
Clin Microbiol Infect. 2021 Apr;27(4):639-640. doi: 10.1016/j.cmi.2020.09.039. Epub 2020 Sep 29.
2
Impact of convalescent and nonimmune plasma on mortality of patients with COVID-19: a potential role for antithrombin.康复期血浆和非免疫血浆对COVID-19患者死亡率的影响：抗凝血酶的潜在作用。
Clin Microbiol Infect. 2021 Apr;27(4):637-638. doi: 10.1016/j.cmi.2020.09.007. Epub 2020 Sep 9.
3
In Reply-How Safe Is COVID-19 Convalescent Plasma?回复——新冠康复者血浆有多安全？
Mayo Clin Proc. 2021 Aug;96(8):2281-2282. doi: 10.1016/j.mayocp.2021.06.010. Epub 2021 Jun 25.
4
Convalescent Plasma for Outpatients with Covid-19. Reply.用于新冠门诊患者的康复期血浆。回复。
N Engl J Med. 2021 Dec 2;385(23):2206-2207. doi: 10.1056/NEJMc2114591. Epub 2021 Oct 13.
5
Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19.
Nat Med. 2022 Jan;28(1):53-58. doi: 10.1038/s41591-021-01639-5. Epub 2022 Jan 10.
6
In Reply - Micro-Thrombosis, Perfusion Defects, and Worsening Oxygenation in COVID-19 Patients: A Word of Caution on the Use of Convalescent Plasma.回复——新冠病毒感染患者中的微血栓形成、灌注缺陷及氧合恶化：关于使用恢复期血浆的一则警示
Mayo Clin Proc. 2021 Jan;96(1):259-261. doi: 10.1016/j.mayocp.2020.10.036. Epub 2020 Nov 3.
7
In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.回复——关于COVID-19患者恢复期血浆输注安全性更新的局限性
Mayo Clin Proc. 2020 Dec;95(12):2802-2803. doi: 10.1016/j.mayocp.2020.09.032. Epub 2020 Oct 1.
8
Convalescent plasma for COVID-19 considerations.关于新冠病毒病恢复期血浆的考量
Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.
9
[Is convalescent plasma an alternative treatment for Covid-19 patients?].[康复期血浆是新冠病毒肺炎患者的替代治疗方法吗？]
Salud Publica Mex. 2020 Nov-Dec;62(6):870-871. doi: 10.21149/11744.
10
Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.用于治疗新冠病毒肺炎的康复期血浆——解读其中的不一致之处
N Engl J Med. 2022 May 5;386(18):1753-1754. doi: 10.1056/NEJMe2204332.
本文引用的文献
1
Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity.COVID-19 患者的抗凝血酶与死亡率之间的关联。与肥胖之间可能存在联系。
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1914-1919. doi: 10.1016/j.numecd.2020.07.040. Epub 2020 Jul 28.
2
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.用恢复期血浆治疗 COVID-19：从过去的冠状病毒爆发中吸取的教训。
Clin Microbiol Infect. 2020 Oct;26(10):1436-1446. doi: 10.1016/j.cmi.2020.08.005. Epub 2020 Aug 11.
3
Thromboprophylaxis for medical inpatients with coronavirus disease 2019.2019年冠状病毒病成年住院患者的血栓预防
Clin Microbiol Infect. 2020 Sep;26(9):1125-1126. doi: 10.1016/j.cmi.2020.05.021. Epub 2020 May 23.
4
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.COVID-19 急性呼吸窘迫综合征患者的促凝模式。
J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6.
Zotero 插件